Interplay between innate immunity and negative-strand RNA viruses: Towards a rational model

Microbiology and Molecular Biology Reviews

Volumn 75, Issue 3, 2011, Pages 468-490

  Gerlier, Denis ^a,b   Lyles, Douglas S ^c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL PROTEIN; DOUBLE STRANDED RNA; INTERFERON; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; VIRUS RNA;

CYTOKINE RESPONSE; CYTOSOL; GENE ACTIVATION; GENETIC VARIABILITY; HOST; HUMAN; INNATE IMMUNITY; INTERFERON INDUCTION; MONONEGAVIRALES INFECTION; NONHUMAN; PROTEIN DNA BINDING; REVIEW; RNA STRUCTURE; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CYTOSOL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INTERFERONS; MODELS, BIOLOGICAL; MONONEGAVIRALES; MONONEGAVIRALES INFECTIONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PATTERN RECOGNITION; RNA, VIRAL; SIGNAL TRANSDUCTION;

RNA VIRUSES;

EID: 80052705992     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00007-11     Document Type: Review

References (319)

1. Ahmed, M., K. L. Brzoza, and E. M. Hiltbold. 2006. Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J. Virol. 80:2194-2205. (Pubitemid 43271526)
2. Ahmed, M., S. D. Cramer, and D. S. Lyles. 2004. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses. Virology 330:34-49. (Pubitemid 39446565)
3. Ahmed, M., and D. S. Lyles. 1998. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J. Virol. 72:8413-8419. (Pubitemid 28421849)
4. Ahmed, M., T. R. Marino, S. Puckett, N. D. Kock, and D. S. Lyles. 2008. Immune response in the absence of neurovirulence in mice infected with M protein mutant vesicular stomatitis virus. J. Virol. 82:9273-9277.
5. Ahmed, M., et al. 2003. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J. Virol. 77:4646-4657. (Pubitemid 36402814)
6. Ahmed, M., et al. 2009. Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms. J. Virol. 83:2962-2975.
7. Albertini, A. A., et al. 2006. Crystal structure of the rabies virus nucleoprotein- RNA complex. Science 313:360-363. (Pubitemid 44480962)
8. Atreya, P. L., M. E. Peeples, and P. L. Collins. 1998. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J. Virol. 72:1452-1461. (Pubitemid 28116933)
9. Babu, J. R., et al. 2003. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160:341-353. (Pubitemid 36182725)
10. Bamming, D., and C. M. Horvath. 2009. Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2. J. Biol. Chem. 284:9700-9712.
11. Barchet, W., et al. 2002. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195:507-516. (Pubitemid 34461303)
12. Barna, M., T. Komatsu, Z. Bi, and C. S. Reiss. 1996. Sex differences in susceptibility to viral infection of the central nervous system. J. Neuroimmunol. 67:31-39. (Pubitemid 26245701)
13. Baron, M. D., and T. Barrett. 2000. Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs. J. Virol. 74:2603-2611. (Pubitemid 30117569)
14. Baum, A., R. Sachidanandam, and A. Garcia-Sastre. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by nextgeneration sequencing. Proc. Natl. Acad. Sci. U. S. A. 107:16303-16308.
15. Belanger, F., J. Stepinski, E. Darzynkiewicz, and J. Pelletier. 2010. Characterization of hMTr1, a human Cap1 2'-O-ribose methyltransferase. J. Biol. Chem. 285:33037-33044.
16. Bernasconi, D., U. Schultz, and P. Staeheli. 1995. The interferon-induced Mx protein of chickens lacks antiviral activity. J. Interferon Cytokine Res. 15:47-53.
17. Bhoj, V. G., et al. 2008. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 105:14046-14051.
18. Bi, Z., M. Barna, T. Komatsu, and C. S. Reiss. 1995. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466-6472.
19. Bitko, V., and S. Barik. 2001. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1:34.
20. Bitko, V., A. Musiyenko, M. A. Bayfield, R. J. Maraia, and S. Barik. 2008. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J. Virol. 82:7977-7987.
21. Black, B. L., G. Brewer, and D. S. Lyles. 1994. Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo. J. Virol. 68:555-560.
22. Black, B. L., R. B. Rhodes, M. McKenzie, and D. S. Lyles. 1993. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J. Virol. 67:4814-4821. (Pubitemid 23215962)
23. Bloor, S., J. Maelfait, R. Krumbach, R. Beyaert, and F. Randow. 2010. Endoplasmic reticulum chaperone gp96 is essential for infection with vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 107:6970-6975.
24. Blower, M. D., M. Nachury, R. Heald, and K. Weis. 2005. A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly. Cell 121:223-234. (Pubitemid 40546390)
25. Blumberg, B. M., C. Giorgi, and D. Kolakofsky. 1983. N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell 32:559-567.
26. Blumberg, B. M., and D. Kolakofsky. 1981. Intracellular vesicular stomatitis virus leader RNAs are found in nucleocapsid structures. J. Virol. 40:568-576. (Pubitemid 12234043)
27. Blumberg, B. M., M. Leppert, and D. Kolakofsky. 1981. Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell 23:837-845.
28. Boonyaratanakornkit, J., et al. 2011. The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J. Virol. 85: 1495-1506.
29. Bousquet-Antonelli, C., and J. M. Deragon. 2009. A comprehensive analysis of the La-motif protein superfamily. RNA 15:750-764.
30. Boxer, E. L., S. K. Nanda, and M. D. Baron. 2009. The rinderpest virus non-structural C protein blocks the induction of type 1 interferon. Virology 385:134-142.
31. Brzozka, K., S. Finke, and K. K. Conzelmann. 2005. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79:7673-7681. (Pubitemid 40756801)
32. Brzozka, K., S. Finke, and K. K. Conzelmann. 2006. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 80:2675-2683. (Pubitemid 43346363)
33. Butchi, N. B., M. Du, and K. E. Peterson. 2010. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 58:650-664.
34. Cadd, T., et al. 1996. The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J. Virol. 70:5067-5074. (Pubitemid 26240677)
35. Caignard, G., et al. 2007. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 368:351-362. (Pubitemid 350019486)
36. Calain, P., and L. Roux. 1993. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:4822-4830. (Pubitemid 23215963)
37. Cao, W., and Y. J. Liu. 2007. Innate immune functions of plasmacytoid dendritic cells. Curr. Opin. Immunol. 19:24-30. (Pubitemid 46073695)
38. Cardenas, W. B., et al. 2006. Ebola virus VP35 protein binds doublestranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80:5168-5178.
39. Carlos, T. S., D. F. Young, M. Schneider, J. P. Simas, and R. E. Randall. 2009. Parainfluenza virus 5 genomes are located in viral cytoplasmic bodies whilst the virus dismantles the interferon-induced antiviral state of cells. J. Gen. Virol. 90:2147-2156.
40. Castaneda, S. J., and T. C. Wong. 1990. Leader sequence distinguishes between translatable and encapsidated measles virus RNAs. J. Virol. 64: 222-230. (Pubitemid 20032620)
41. Castanier, C., D. Garcin, A. Vazquez, and D. Arnoult. 2010. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep. 11:133-138.
42. Cattaneo, R., and M. A. Billeter. 1992. Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176: 63-74.
43. Cattaneo, R., et al. 1987. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:681-688.
44. Chakraborty, P., et al. 2009. Vesicular stomatitis virus inhibits mitotic progression and triggers cell death. EMBO Rep. 10:1154-1160.
45. Chang, T. H., et al. 2009. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 5:e1000493.
46. Chattopadhyay, S., et al. 2010. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J. 29:1762-1773.
47. Chattopadhyay, S., M. Yamashita, Y. Zhang, and G. C. Sen. 2011. The IRF-3/Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J. Virol. 85:3708-3716.
48. Chauhan, V. S., et al. 2010. Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. Virology 400:187-196.
49. Chen, S., et al. 2010. Heterocellular induction of interferon by negativesense RNA viruses. Virology 407:247-255.
50. Childs, K., et al. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200. (Pubitemid 46223502)
51. Childs, K. S., J. Andrejeva, R. E. Randall, and S. Goodbourn. 2009. Mechanism of mda-5 Inhibition by paramyxovirus V proteins. J. Virol. 83:1465-1473.
52. Ciancanelli, M. J., V. A. Volchkova, M. L. Shaw, V. E. Volchkov, and C. F. Basler. 2009. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J. Virol. 83:7828-7841.
53. Colby, C., and M. J. Chamberlin. 1969. The specificity of interferon induction in chick embryo cells by helical RNA. Proc. Natl. Acad. Sci. U. S. A. 63:160-167.
54. Colonno, R. J., and A. K. Banerjee. 1976. A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell 8:197-204.
55. Conzelmann, K. K. 2005. Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J. Virol. 79:5241-5248.
56. Cui, S., et al. 2008. The C-terminal regulatory domain is the RNA 5'- triphosphate sensor of RIG-I. Mol. Cell 29:169-179. (Pubitemid 351172822)
57. Curran, J., J. B. Marq, and D. Kolakofsky. 1992. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 189:647-656.
58. Daffis, S., et al. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456.
59. De, B. P., S. Gupta, H. Zhao, J. A. Drazba, and A. K. Banerjee. 1996. Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3. J. Biol. Chem. 271:24728-24735. (Pubitemid 26333217)
60. Devaux, P., et al. 2011. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J. Virol. 85:348-356.
61. Devaux, P., V. von Messling, W. Songsungthong, C. Springfeld, and R. Cattaneo. 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360:72-83.
62. DeWitte-Orr, S. J., et al. 2009. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. J. Immunol. 183:6545-6553.
63. Diaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227:220-228. (Pubitemid 27241073)
64. Dixit, E., et al. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141:668-681.
65. Duhen, T., et al. 2010. Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus. Virus Res. 152:115-125.
66. Dunn, E. F., and J. H. Connor. 2011. Dominant inhibition of Akt/PKB signaling by the matrix protein of a negative-strand RNA virus. J. Virol. 85:422-431.
67. Durbin, R. K., S. E. Mertz, A. E. Koromilas, and J. E. Durbin. 2002. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol. 15:41-51. (Pubitemid 34273437)
68. Elliott, J., et al. 2007. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J. Virol. 81:3428-3436. (Pubitemid 46456651)
69. Espert, L., et al. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278:16151-16158. (Pubitemid 36799737)
70. Falkenberg, M., N. G. Larsson, and C. M. Gustafsson. 2007. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 76:679-699.
71. Fan, H., J. L. Goodier, J. R. Chamberlain, D. R. Engelke, and R. J. Maraia. 1998. 5' processing of tRNA precursors can be modulated by the human La antigen phosphoprotein. Mol. Cell. Biol. 18:3201-3211. (Pubitemid 28240493)
72. Faria, P. A., et al. 2005. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 17:93-102. (Pubitemid 40075368)
73. Faul, E. J., D. S. Lyles, and M. J. Schnell. 2009. Interferon response and viral evasion by members of the family Rhabdoviridae. Viruses 1:832-851.
74. Faul, E. J., et al. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016.
75. Ferran, M. C., and J. M. Lucas-Lenard. 1997. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 71:371-377. (Pubitemid 26412301)
76. Finke, S., and K. K. Conzelmann. 1997. Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negativestrand ribonucleoprotein complexes into rabies virions. J. Virol. 71:7281-7288. (Pubitemid 27391664)
77. Fontana, J. M., B. Bankamp, W. J. Bellini, and P. A. Rota. 2008. Regulation of interferon signaling by the C and V proteins from attenuated and wildtype strains of measles virus. Virology 374:71-81.
78. Francoeur, A. M., L. Poliquin, and C. P. Stanners. 1987. The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology 160:236-245.
79. Furr, S. R., V. S. Chauhan, D. Sterka, Jr., V. Grdzelishvili, and I. Marriott. 2008. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J. Neurovirol. 14:503-513.
80. Gack, M. U., et al. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. U. S. A. 105:16743-16748.
81. Gack, M. U., et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. (Pubitemid 46633167)
82. Garcin, D., P. Latorre, and D. Kolakofsky. 1999. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73:6559-6565. (Pubitemid 29327837)
83. Gee, P., et al. 2008. Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J. Biol. Chem. 283:9488-9496.
84. Gerlier, D. Emerging zoonotic viruses: new lessons on receptor and entry mechanisms. Curr. Opin. Virol. 1:27-34.
85. Gerlier, D., and H. Valentin. 2009. Measles virus interaction with host cells and impact on innate immunity. Curr. Top. Microbiol. Immunol. 329:163-191.
86. Gitlin, L., et al. 2010. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog. 6:e1000734.
87. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81:2341-2364.
88. Goodbourn, S., and R. E. Randall. 2009. The regulation of type I interferon production by paramyxoviruses. J. Interferon Cytokine Res. 29:539-547.
89. Gotoh, B., et al. 1999. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett. 459:205-210. (Pubitemid 29475031)
90. Grandvaux, N., M. J. Servant, B. tenOever, et al. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:5532-5539. (Pubitemid 34517903)
91. Green, T. J., et al. 2011. Access to RNA encapsidated in the nucleocapsid of vesicular stomatitis virus. J. Virol. 85:2714-2722.
92. Green, T. J., X. Zhang, G. W. Wertz, and M. Luo. 2006. Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science 313:357-360. (Pubitemid 44480961)
93. Gupta, K. C., and D. W. Kingsbury. 1985. Polytranscripts of Sendai virus do not contain intervening polyadenylate sequences. Virology 141:102-109. (Pubitemid 15133183)
94. Habjan, M., et al. 2008. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032.
95. Halpin, K., B. Bankamp, B. H. Harcourt, W. J. Bellini, and P. A. Rota. 2004. Nipah virus conforms to the rule of six in a minigenome replication assay. J. Gen. Virol. 85:701-707. (Pubitemid 38379874)
96. Hartman, A. L., et al. 2008. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of Ebola virus. J. Virol. 82:2699-2704. (Pubitemid 351329161)
97. Hartman, A. L., J. E. Dover, J. S. Towner, and S. T. Nichol. 2006. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J. Virol. 80:6430-6440. (Pubitemid 43927446)
98. Hartman, A. L., L. Ling, S. T. Nichol, and M. L. Hibberd. 2008. Wholegenome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J. Virol. 82:5348-5358. (Pubitemid 351705242)
99. Hartner, J. C., C. R. Walkley, J. Lu, and S. H. Orkin. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 10:109-115.
100. Hausmann, S., J. B. Marq, C. Tapparel, D. Kolakofsky, and D. Garcin. 2008. RIG-I and dsRNA-induced IFNbeta activation. PLoS One 3:e3965.
101. Hayakawa, S., et al. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12:37-44.
102. Her, L. S., E. Lund, and J. E. Dahlberg. 1997. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276:1845-1848. (Pubitemid 27443658)
103. Holmes, E. C. 2010. The RNA virus quasispecies: fact or fiction? J. Mol. Biol. 400:271-273.
104. Horikami, S. M., R. E. Hector, S. Smallwood, and S. A. Moyer. 1997. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology 235:261-270. (Pubitemid 27394339)
105. Horikami, S. M., and S. A. Moyer. 1991. Synthesis of leader RNA and editing of the P mRNA during transcription by purified measles virus. J. Virol. 65:5342-5347.
106. Hornung, V., et al. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
107. Hu, J., et al. 2010. A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J. Immunol. 185:424-432.
108. Huang, Y., M. A. Bayfield, R. V. Intine, and R. J. Maraia. 2006. Separate RNA-binding surfaces on the multifunctional La protein mediate distinguishable activities in tRNA maturation. Nat. Struct. Mol. Biol. 13:611-618. (Pubitemid 44036471)
109. Huhn, P., G. J. Pruijn, W. J. van Venrooij, and M. Bachmann. 1997. Characterization of the autoantigen La (SS-B) as a dsRNA unwinding enzyme. Nucleic Acids Res. 25:410-416. (Pubitemid 27303336)
110. Huneycutt, B. S., et al. 1994. Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis. Brain Res. 635:81-95. (Pubitemid 24031391)
111. Iannacone, M., et al. 2010. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465:1079-1083.
112. Ikegame, S., et al. 2010. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J. Virol. 84:372-379.
113. Inn, K. S., et al. 2011. Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction. Mol. Cell 41:354-365.
114. Isaacs, A., and J. Lindenmann. 1957. Virus interference. I. The interferon. Proc. R Soc. Lond. B Biol. Sci. 147:258-267.
115. Isaacs, A., J. Lindenmann, and R. C. Valentine. 1957. Virus interference. II. Some properties of interferon. Proc. R Soc. Lond. B Biol. Sci. 147:268-273.
116. Iseni, F., et al. 2002. Sendai virus trailer RNA binds TIAR, a cellular protein involved in virus-induced apoptosis. EMBO J. 21:5141-5150.
117. Ito, N., et al. 2010. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 84:6699-6710.
118. Janeway, C. A., Jr, C. C. Goodnow, and R. Medzhitov. 1996. Danger-pathogen on the premises! Immunological tolerance. Curr. Biol. 6:519-522.
119. Johansen, L. D., et al. 2008. IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration. J. Cell Sci. 121:854-864. (Pubitemid 351578121)
120. Johnson, N., et al. 2008. Inflammatory responses in the nervous system of mice infected with a street isolate of rabies virus. Dev. Biol. (Basel) 131: 65-72.
121. Johnson, N., et al. 2006. Lyssavirus infection activates interferon gene expression in the brain. J. Gen. Virol. 87:2663-2667.
122. Kanneganti, T. D. 2010. Central roles of NLRs and inflammasomes in viral infection. Nat. Rev. Immunol. 10:688-698.
123. Kato, H., et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28. (Pubitemid 41019654)
124. Kato, H., et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation- associated gene 5. J. Exp. Med. 205:1601-1610. (Pubitemid 351962024)
125. Kawai, T., and S. Akira. 2007. TLR signaling. Semin. Immunol. 19:24-32. (Pubitemid 46498752)
126. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650.
127. Kawai, T., et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5- mediated type I interferon induction. Nat. Immunol. 6:981-988. (Pubitemid 41486182)
128. Keene, J. D. 2007. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 8:533-543. (Pubitemid 46955210)
129. Kessler, J. R., J. R. Kremer, and C. P. Muller. 2011. Interplay of measles virus with early induced cytokines reveals different wild type phenotypes. Virus Res. 155:195-202.
130. Khabar, K. S., et al. 2000. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of RNase L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20:653-659. (Pubitemid 30481718)
131. Killip, M. J., et al. 2011. Failure to activate the IFN-beta promoter by a paramyxovirus lacking an interferon antagonist. Virology 415:39-46.
132. Kim, H., and B. Seed. 2010. The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3. Nat. Immunol. 11:743-750.
133. Kim, M. J., S. Y. Hwang, T. Imaizumi, and J. Y. Yoo. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferoninduced ISG15 conjugation. J. Virol. 82:1474-1483.
134. Kimberlin, C. R., et al. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc. Natl. Acad. Sci. U. S. A. 107:314-319.
135. Kitagawa, Y., et al. 2011. A tryptophan-rich motif in the human parainfluenza virus type 2 V protein is critical for the blockade of Toll-like receptor 7 (TLR7)- and TLR9-dependent signaling. J. Virol. 85:4606-4611.
136. Kolakofsky, D., P. Le Mercier, F. Iseni, and D. Garcin. 2004. Viral RNA polymerase scanning and the gymnastics of Sendai virus RNA synthesis. Virology 318:463-473. (Pubitemid 38224290)
137. Kolakofsky, D., et al. 1998. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J. Virol. 72:891-899. (Pubitemid 28116865)
138. Kolakofsky, D., L. Roux, D. Garcin, and R. W. Ruigrok. 2005. Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis. J. Gen. Virol. 86:1869-1877. (Pubitemid 40916369)
139. Komuro, A., D. Bamming, and C. M. Horvath. 2008. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43:350-358.
140. Komuro, A., and C. M. Horvath. 2006. RNA- and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 80:12332-12342. (Pubitemid 44904383)
141. Kumagai, Y., et al. 2007. Alveolar macrophages are the primary interferonalpha producer in pulmonary infection with RNA viruses. Immunity 27: 240-252. (Pubitemid 47284930)
142. Kurilla, M. G., C. D. Cabradilla, B. P. Holloway, and J. D. Keene. 1984. Nucleotide sequence and host La protein interactions of rabies virus leader RNA. J. Virol. 50:773-778. (Pubitemid 14104262)
143. Kurilla, M. G., and J. D. Keene. 1983. The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell 34:837-845. (Pubitemid 13023353)
144. Lamb, R. A., and G. D. Parks. 2007. Paramyxoviridae: the viruses and their replication, p. 1449-1496. In B. N. Fields and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, PA.
145. Landis, H., et al. 1998. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72:1516-1522. (Pubitemid 28116940)
146. Lang, K. S., et al. 2007. MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus. Eur. J. Immunol. 37:2434-2440.
147. Le Mercier, P., D. Garcin, S. Hausmann, and D. Kolakofsky. 2002. Ambisense Sendai viruses are inherently unstable but are useful to study viral RNA synthesis. J. Virol. 76:5492-5502. (Pubitemid 34517899)
148. Lemon, K., et al. 2011. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 7:e1001263.
149. Leppert, M., and D. Kolakofsky. 1978. 5' terminus of defective and nondefective Sendai viral genomes is ppp Ap. J. Virol. 25:427-432. (Pubitemid 8259287)
150. Leppert, M., and D. Kolakofsky. 1980. Effect of defective interfering particles on plus- and minus-strand leader RNAs in vesicular stomatitis virusinfected cells. J. Virol. 35:704-709. (Pubitemid 11217800)
151. Leppert, M., L. Rittenhouse, J. Perrault, D. F. Summers, and D. Kolakofsky. 1979. Plus and minus strand leader RNAs in negative strand virusinfected cells. Cell 18:735-747. (Pubitemid 10216998)
152. Leroy, M., E. Baise, G. Pire, J. Gerardin, and D. Desmecht. 2005. Resistance of paramyxoviridae to type I interferon-induced Bos taurus Mx1 dynamin. J. Interferon Cytokine Res. 25:192-201. (Pubitemid 40525306)
153. Leroy, M., G. Pire, E. Baise, and D. Desmecht. 2006. Expression of the interferon-alpha/beta-inducible bovine Mx1 dynamin interferes with replication of rabies virus. Neurobiol. Dis. 21:515-521. (Pubitemid 43277534)
154. Leroy, M. P., E. A. Baise, G. A. Pire, and D. J. Desmecht. 2007. Contribution of MX dynamin, oligoadenylate synthetase, and protein kinase R to anti-paramyxovirus activity of type 1 interferons in vitro. Am. J. Vet. Res. 68:988-994. (Pubitemid 47408329)
155. Leung, D. W., et al. 2009. Structure of the Ebola VP35 interferon inhibitory domain. Proc. Natl. Acad. Sci. U. S. A. 106:411-416.
156. Li, J., A. Rahmeh, V. Brusic, and S. P. Whelan. 2009. Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis. J. Virol. 83:1930-1940.
157. Li, J., J. T. Wang, and S. P. Whelan. 2006. A unique strategy for mRNA cap methylation used by vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 103:8493-8498. (Pubitemid 43838483)
158. Li, X., et al. 2009. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch. Biochem. Biophys. 488:23-33.
159. Li, X., et al. 2009. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J. Biol. Chem. 284:13881-13891.
160. Ling, Z., K. C. Tran, and M. N. Teng. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83:3734-3742.
161. Lipardi, C., and B. M. Paterson. 2009. Identification of an RNA-dependent RNA polymerase in Drosophila involved in RNAi and transposon suppression. Proc. Natl. Acad. Sci. U. S. A. 106:15645-15650.
162. Liuzzi, M., et al. 2005. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J. Virol. 79:13105-13115. (Pubitemid 41433229)
163. Longhi, S. 2009. Nucleocapsid structure and function. Curr. Top. Microbiol. Immunol. 329:103-128.
164. Loo, Y. M., et al. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82:335-345.
165. Lu, C., et al. 2010. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 18:1032-1043.
166. Lu, L. L., M. Puri, C. M. Horvath, and G. C. Sen. 2008. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 283: 14269-14276.
167. Luber, C. A., et al. 2010. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32:279-289.
168. Ludewig, B., et al. 2000. Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs. Eur. J. Immunol. 30:185-196. (Pubitemid 30011779)
169. Luthra, P., D. Sun, R. H. Silverman, and B. He. 2011. Activation of IFN-βexpression by a viral mRNA through RNase L and MDA5. Proc. Natl. Acad. Sci. U. S. A. 108:2118-2123.
170. Lynch, S., and D. Kolakofsky. 1978. Ends of the RNA within Sendai virus defective interfering nucleocapsids are not free. J. Virol. 28:584-589. (Pubitemid 9041714)
171. Malur, A. G., M. A. Hoffman, and A. K. Banerjee. 2004. The human parainfluenza virus type 3 (HPIV 3) C protein inhibits viral transcription. Virus Res. 99:199-204. (Pubitemid 38121669)
172. Manuse, M. J., and G. D. Parks. 2009. Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. J. Virol. 83:9057-9067.
173. Marcus, P. I., D. L. Engelhardt, J. M. Hunt, and M. J. Sekellick. 1971. Interferon action: inhibition of vesicular stomatitis virus RNA synthesis induced by virion-bound polymerase. Science 174:593-598.
174. Marcus, P. I., and M. J. Sekellick. 1977. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 266:815-819. (Pubitemid 8074709)
175. Marcus, P. I., and M. J. Sekellick. 1978. Interferon action. III. The rate of primary transcription of vesicular stomatitis virus is inhibited by interferon action. J. Gen. Virol. 38:391-408. (Pubitemid 8273321)
176. Marcus, P. I., and M. J. Sekellick. 1980. Interferon induction by viruses. III. Vesicular stomatitis virus: interferon-inducing particle activity requires partial transcription of gene N. J. Gen. Virol. 47:89-96. (Pubitemid 10105191)
177. Marq, J. B., S. Hausmann, N. Veillard, D. Kolakofsky, and D. Garcin. 2011. Short double-stranded RNAs with an overhanging 5' ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J. Biol. Chem. 286:6108-6116.
178. Marq, J. B., D. Kolakofsky, and D. Garcin. 2010. Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I. J. Biol. Chem. 285:18208-18216.
179. Marques, J. T., et al. 2006. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24:559-565.
180. Mas, A., C. Lopez-Galindez, I. Cacho, J. Gomez, and M. A. Martinez. 2010. Unfinished stories on viral quasispecies and Darwinian views of evolution. J. Mol. Biol. 397:865-877.
181. Masters, P. S., and C. E. Samuel. 1984. Detection of in vivo synthesis of polycistronic mRNAs of vesicular stomatitis virus. Virology 134:277-286. (Pubitemid 14107426)
182. Mateo, M., S. P. Reid, L. W. Leung, C. F. Basler, and V. E. Volchkov. 2010. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J. Virol. 84:1169-1175.
183. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301-305. (Pubitemid 34303674)
184. McAllister, C. S., et al. 2010. Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus. J. Virol. 84:380-386.
185. Mendonca, R. Z., and C. A. Pereira. 1994. Relationship of interferon synthesis and the resistance of mice infected with street rabies virus. Braz. J. Med. Biol. Res. 27:691-695. (Pubitemid 24117005)
186. Meylan, E., et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. (Pubitemid 41509355)
187. Morimoto, K., H. D. Foley, J. P. McGettigan, M. J. Schnell, and B. Dietzschold. 2000. Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J. Neurovirol. 6:373-381.
188. Moseley, G. W., R. P. Filmer, M. A. DeJesus, and D. A. Jans. 2007. Nucleocytoplasmic distribution of rabies virus P-protein is regulated by phosphorylation adjacent to C-terminal nuclear import and export signals. Biochemistry 46:12053-12061. (Pubitemid 350027404)
189. Moseley, G. W., et al. 2009. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J. Cell Sci. 122:3652-3662.
190. Mottet-Osman, G., et al. 2007. Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J. Virol. 81:2861-2868. (Pubitemid 46447049)
191. Mottet, G., J. Curran, and L. Roux. 1990. Intracellular stability of nonreplicating paramyxovirus nucleocapsids. Virology 176:1-7. (Pubitemid 20149661)
192. Mueller, S., et al. 2010. RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 107:19390-19395.
193. Muller, U., et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921. (Pubitemid 24245635)
194. Murali, A., et al. 2008. Structure and function of LGP2, a DEX(D/H) helicase that regulates the innate immunity response. J. Biol. Chem. 283: 15825-15833.
195. Myong, S., et al. 2009. Cytosolic viral sensor RIG-I is a 5'-triphosphatedependent translocase on double-stranded RNA. Science 323:1070-1074.
196. Nakatsu, Y., M. Takeda, S. Ohno, R. Koga, and Y. Yanagi. 2006. Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J. Virol. 80:11861-11867. (Pubitemid 44788897)
197. Nakayama, Y., et al. 2010. Role of PKR and type I IFNs in viral control during primary and secondary infection. PLoS Pathog. 6:e1000966.
198. Nallagatla, S. R., et al. 2007. 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318:1455-1458. (Pubitemid 350208957)
199. Nanbo, A., et al. 2010. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6:e1001121.
200. Naniche, D., et al. 2000. Evasion of host defenses by measles virus: wildtype measles virus infection interferes with induction of alpha/beta interferon production. J. Virol. 74:7478-7484. (Pubitemid 30613093)
201. Nishie, T., K. Nagata, and K. Takeuchi. 2007. The C protein of wild-type measles virus has the ability to shuttle between the nucleus and the cytoplasm. Microbes Infect. 9:344-354. (Pubitemid 46341935)
202. Nishikura, K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 79:321-349.
203. Nistal-Villan, E., et al. 2010. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J. Biol. Chem. 285: 20252-20261.
204. Noton, S. L., V. M. Cowton, C. R. Zack, D. R. McGivern, and R. Fearns. 2010. Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion. Proc. Natl. Acad. Sci. U. S. A. 107:10226-10231.
205. Ogino, T., and A. K. Banerjee. 2010. The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity. J. Gen. Virol. 91:1311-1314.
206. Ogino, T., S. P. Yadav, and A. K. Banerjee. 2010. Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 107:3463-3468.
207. O'Neill, L. A., and A. G. Bowie. 2010. Sensing and signaling in antiviral innate immunity. Curr. Biol. 20:R328-333.
208. Onoguchi, K., et al. 2010. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog. 6:e1001012.
209. Osiak, A., O. Utermohlen, S. Niendorf, I. Horak, and K. P. Knobeloch. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25:6338-6345. (Pubitemid 41023211)
210. Palosaari, H., J. P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644. (Pubitemid 36734533)
211. Panne, D. 2008. The enhanceosome. Curr. Opin. Struct. Biol. 18:236-242.
212. Parisien, J. P., et al. 2009. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J. Virol. 83: 7252-7260.
213. Peeters, B. P., Y. K. Gruijthuijsen, O. S. de Leeuw, and A. L. Gielkens. 2000. Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch. Virol. 145:1829-1845.
214. Pernet, O., C. Pohl, M. Ainouze, H. Kweder, and R. Buckland. 2009. Nipah virus entry can occur by macropinocytosis. Virology 395:298-311.
215. Pfaller, C. K., and K. K. Conzelmann. 2008. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J. Virol. 82:12365-12373.
216. Pichlmair, A., et al. 2009. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83:10761-10769.
217. Pippig, D. A., et al. 2009. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res. 37:2014-2025.
218. Plakhov, I. V., E. E. Arlund, C. Aoki, and C. S. Reiss. 1995. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257-262.
219. Plumet, S., W. P. Duprex, and D. Gerlier. 2005. Dynamics of viral RNA synthesis during measles virus infection. J. Virol. 79:6900-6908. (Pubitemid 40677321)
220. Plumet, S., and D. Gerlier. 2005. Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J. Virol. Methods 128:79-87. (Pubitemid 40980213)
221. Plumet, S., et al. 2007. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279.
222. Pothlichet, J., et al. 2009. Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response. PLoS One 4:e7582.
223. Prins, K. C., W. B. Cardenas, and C. F. Basler. 2009. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 83:3069-3077.
224. Prins, K. C., et al. 2010. Mutations abrogating VP35 interaction with double- stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 84:3004-3015.
225. Raha, T., R. Pudi, S. Das, and M. S. Shaila. 2004. Leader RNA of Rinderpest virus binds specifically with cellular La protein: a possible role in virus replication. Virus Res. 104:101-109. (Pubitemid 38891745)
226. Rahmeh, A. A., J. Li, P. J. Kranzusch, and S. P. Whelan. 2009. Ribose 2'-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein. J. Virol. 83:11043-11050.
227. Ramachandran, A., and C. M. Horvath. 2010. Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J. Virol. 84: 11152-11163.
228. Ramachandran, A., and C. M. Horvath. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J. Interferon Cytokine Res. 29:531-537.
229. Randall, R. E., and S. Goodbourn. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47.
230. Ranjith-Kumar, C. T., et al. 2009. Agonist and antagonist recognition by RIG-I, a cytoplasmic innate immunity receptor. J. Biol. Chem. 284:1155-1165.
231. Rao, D. D., and A. S. Huang. 1979. Synthesis of a small RNA in cells coinfected by standard and defective interfering particles of vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 76:3742-3745. (Pubitemid 9246451)
232. Re, G. G., E. M. Morgan, and D. W. Kingsbury. 1985. Nucleotide sequences responsible for generation of internally deleted Sendai virus defective interfering genomes. Virology 146:27-37. (Pubitemid 15225494)
233. Rehwinkel, J., et al. 2010. RIG-I detects viral genomic RNA during negative- strand RNA virus infection. Cell 140:397-408.
234. Reid, S. P., W. B. Cardenas, and C. F. Basler. 2005. Homo-oligomerization facilitates the interferon-antagonist activity of the Ebolavirus VP35 protein. Virology 341:179-189. (Pubitemid 41416728)
235. Reid, S. P., et al. 2006. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80:5156-5167.
236. Reid, S. P., C. Valmas, O. Martinez, F. M. Sanchez, and C. F. Basler. 2007. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 81:13469-13477. (Pubitemid 350252964)
237. Reuter, T., B. Weissbrich, S. Schneider-Schaulies, and J. Schneider-Schaulies. 2006. RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription. J. Virol. 80:5951-5957. (Pubitemid 43849172)
238. Reutter, G. L., C. Cortese-Grogan, J. Wilson, and S. A. Moyer. 2001. Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology 285:100-109. (Pubitemid 32589012)
239. Rieder, M., et al. 2011. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J. Virol. 85:842-852.
240. Rima, B. K., and W. P. Duprex. 2009. The measles virus replication cycle. Curr. Top. Microbiol. Immunol. 329:77-102.
241. Rodriguez, M. S., C. Dargemont, and F. Stutz. 2004. Nuclear export of RNA. Biol. Cell 96:639-655. (Pubitemid 39562237)
242. Rosetto, M., Y. Engstrom, C. T. Baldari, J. L. Telford, and D. Hultmark. 1995. Signals from the IL-1 receptor homolog, Toll, can activate an immune response in a Drosophila hemocyte cell line. Biochem. Biophys. Res. Commun. 209:111-116.
243. Rue, C. A., et al. 2011. Virulent Newcastle disease virus elicits a strong innate immune response in chickens. J. Gen. Virol. 92:931-939.
244. Sabbah, A., et al. 2009. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073-1080.
245. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568. (Pubitemid 351913674)
246. Saito, T., et al. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. U. S. A. 104:582-587. (Pubitemid 46123068)
247. Satoh, T., et al. 2010. LGP2 is a positive regulator of RIG-I- and MDA5- mediated antiviral responses. Proc. Natl. Acad. Sci. U. S. A. 107:1512-1517.
248. Schaap-Nutt, A., et al. 2011. Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates. J. Virol. 85:4007-4019.
249. Schlee, M., et al. 2009. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25-34.
250. Schmeisser, H., et al. 2010. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J. Virol. 84:10671-10680.
251. Schmidt, A., et al. 2009. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc. Natl. Acad. Sci. U. S. A. 106:12067-12072.
252. Schneider, U., M. Schwemmle, and P. Staeheli. 2005. Genome trimming: a unique strategy for replication control employed by Borna disease virus. Proc. Natl. Acad. Sci. U. S. A. 102:3441-3446. (Pubitemid 40328064)
253. Schnell, M. J., J. P. McGettigan, C. Wirblich, and A. Papaneri. 2010. The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Microbiol. 8:51-61.
254. Schoggins, J. W., et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
255. Schuhmann, K. M., C. K. Pfaller, and K. K. Conzelmann. 2011. The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J. Virol. 85:3162-3171.
256. Schulz, O., et al. 2010. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7:354-361.
257. Schuster, A., et al. 1996. Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural cells. Virology 220:241-245. (Pubitemid 26201682)
258. Schwanhausser, B., et al. 2011. Global quantification of mammalian gene expression control. Nature 473:337-342.
259. Sellin, C. I., and B. Horvat. 2009. Current animal models: transgenic animal models for the study of measles pathogenesis. Curr. Top. Microbiol. Immunol. 330:111-127.
260. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. (Pubitemid 41242633)
261. Seto, J., et al. 2010. Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study. J. Virol. 84:10965-10973.
262. Shaffer, J. A., W. J. Bellini, and P. A. Rota. 2003. The C protein of measles virus inhibits the type I interferon response. Virology 315:389-397. (Pubitemid 37324629)
263. Shigemoto, T., et al. 2009. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J. Biol. Chem. 284:13348-13354.
264. Silverman, R. H. 2007. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 81: 12720-12729. (Pubitemid 350156909)
265. Skiadopoulos, M. H., et al. 2003. The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations. J. Virol. 77:270-279. (Pubitemid 36004967)
266. Stojdl, D. F., et al. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74:9580-9585.
267. Stojdl, D. F., et al. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275. (Pubitemid 37329791)
268. Strahle, L., D. Garcin, and D. Kolakofsky. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111. (Pubitemid 44037666)
269. Strahle, L., D. Garcin, P. Le Mercier, J. F. Schlaak, and D. Kolakofsky. 2003. Sendai virus targets inflammatory responses, as well as the interferoninduced antiviral state, in a multifaceted manner. J. Virol. 77:7903-7913. (Pubitemid 36792787)
270. Strahle, L., et al. 2007. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J. Virol. 81:12227-12237. (Pubitemid 350085838)
271. Sun, D., P. Luthra, Z. Li, and B. He. 2009. PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathog. 5:e1000525.
272. Sun, Z., H. Ren, Y. Liu, J. L. Teeling, and J. Gu. 2011. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85:1036-1047.
273. Takahasi, K., et al. 2009. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 284:17465-17474.
274. Takaki, H., et al. 2011. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-beta-inducing potential. Mol. Immunol. 48:497-504.
275. Takeuchi, K., S. I. Kadota, M. Takeda, N. Miyajima, and K. Nagata. 2003. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFNgamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545:177-182. (Pubitemid 36694697)
276. Takeuchi, K., T. Komatsu, Y. Kitagawa, K. Sada, and B. Gotoh. 2008. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J. Virol. 82:10102-10110.
277. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820.
278. Takeuchi, O., and S. Akira. 2007. Recognition of viruses by innate immunity. Immunol. Rev. 220:214-224. (Pubitemid 350045565)
279. Tawar, R. G., et al. 2009. Crystal structure of a nucleocapsid-like nucleoprotein- RNA complex of respiratory syncytial virus. Science 326:1279-1283.
280. Tekes, G., A. A. Rahmeh, and S. P. J. Whelan. 2011. A freeze frame view of vesicular stomatitis virus transcription defines a minimal length of RNA for 5' processing. PLoS Pathog. 7:e1002073.
281. Teplova, M., et al. 2006. Structural basis for recognition and sequestration of UUU(OH) 3' temini of nascent RNA polymerase III transcripts by La, a rheumatic disease autoantigen. Mol. Cell 21:75-85. (Pubitemid 43017850)
282. Timani, K. A., et al. 2008. A single amino acid residue change in the P protein of parainfluenza virus 5 elevates viral gene expression. J. Virol. 82:9123-9133.
283. Toth, A. M., P. Devaux, R. Cattaneo, and C. E. Samuel. 2009. Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus. J. Virol. 83:961-968.
284. Toth, A. M., Z. Li, R. Cattaneo, and C. E. Samuel. 2009. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 284:29350-29356.
285. Trinchieri, G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207: 2053-2063.
286. Trottier, M. D., D. S. Lyles, and C. S. Reiss. 2007. Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection. J. Neurovirol. 13:433-445.
287. Tytell, A. A., G. P. Lampson, A. K. Field, and M. R. Hilleman. 1967. Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). Proc. Natl. Acad. Sci. U. S. A. 58: 1719-1722.
288. Valmas, C., et al. 2010. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog. 6:e1000721.
289. Venkataraman, T., et al. 2007. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178:6444-6455. (Pubitemid 46717428)
290. Vidal, S., and D. Kolakofsky. 1989. Modified model for the switch from Sendai virus transcription to replication. J. Virol. 63:1951-1958. (Pubitemid 19107790)
291. Vidy, A., M. Chelbi-Alix, and D. Blondel. 2005. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79:14411-14420. (Pubitemid 41552738)
292. Vidy, A., J. El Bougrini, M. K. Chelbi-Alix, and D. Blondel. 2007. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 81:4255-4263. (Pubitemid 46586919)
293. Virtue, E. R., G. A. Marsh, and L. F. Wang. 2011. Interferon signaling remains functional during henipavirus infection of human cell lines. J. Virol. 85:4031-4034.
294. von Kobbe, C., et al. 2000. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol. Cell 6:1243-1252.
295. Waibler, Z., C. N. Detje, J. C. Bell, and U. Kalinke. 2007. Matrix protein mediated shutdown of host cell metabolism limits vesicular stomatitis virusinduced interferon-alpha responses to plasmacytoid dendritic cells. Immunobiology 212:887-894. (Pubitemid 350246253)
296. Wang, Y., et al. 2010. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol. 17:781-787.
297. Wang, Z. W., et al. 2005. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 79:12554-12565. (Pubitemid 41346118)
298. Ward, S. V., et al. 2011. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc. Natl. Acad. Sci. U. S. A. 108:331-336.
299. Weber, F., V. Wagner, S. B. Rasmussen, R. Hartmann, and S. R. Paludan. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064.
300. Weichenrieder, O., K. Wild, K. Strub, and S. Cusack. 2000. Structure and assembly of the Alu domain of the mammalian signal recognition particle. Nature 408:167-173.
301. Weidner, J. M., et al. 2010. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84:12646-12657.
302. Whelan, S. P., J. N. Barr, and G. W. Wertz. 2004. Transcription and replication of nonsegmented negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283:61-119. (Pubitemid 38667558)
303. Wiegand, M., S. Bossow, and W. J. Neubert. 2005. Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell typedependent manner. J. Gen. Virol. 86:2305-2314. (Pubitemid 41057535)
304. Wilde, A., C. McQuain, and T. Morrison. 1986. Identification of the sequence content of four polycistronic transcripts synthesized in Newcastle disease virus infected cells. Virus Res. 5:77-95. (Pubitemid 16056711)
305. Wilkins, C., and M. Gale, Jr. 2010. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22:41-47.
306. Wilusz, J., M. G. Kurilla, and J. D. Keene. 1983. A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 80:5827-5831. (Pubitemid 14227568)
307. Wong, R. W., G. Blobel, and E. Coutavas. 2006. Rae1 interaction with NuMA is required for bipolar spindle formation. Proc. Natl. Acad. Sci. U. S. A. 103:19783-19787. (Pubitemid 46037508)
308. Xu, L. G., et al. 2005. VISA is an adapter protein required for virustriggered IFN-beta signaling. Mol. Cell 19:727-740.
309. Yang, Y. K., et al. 2011. ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner. J. Biol. Chem. 286:10568-10580.
310. Yoneyama, M., and T. Fujita. 2010. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 20:4-22.
311. Yoneyama, M., and T. Fujita. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227:54-65.
312. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. (Pubitemid 39023305)
313. Yoneyama, M., K. Onomoto, and T. Fujita. 2008. Cytoplasmic recognition of RNA. Adv. Drug Deliv. Rev. 60:841-846.
314. Yount, J. S., L. Gitlin, T. M. Moran, and C. B. Lopez. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918.
315. Yu, Y., and G. S. Hayward. 2010. The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33:863-877.
316. Zeng, W., et al. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-330.
317. Zhao, C., C. Denison, J. M. Huibregtse, S. Gygi, and R. M. Krug. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102:10200-10205. (Pubitemid 41023349)
318. Zhou, S., et al. 2007. Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J. Immunol. 178:5173-5181. (Pubitemid 46595301)
319. Zust, R., et al. 2011. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12:137-143.